News
As global markets navigate a muted response to new U.S. tariffs and mixed economic signals, the Asian tech sector remains a focal point for investors seeking high growth opportunities. With market ...
10h
Investor's Business Daily on MSNArcutis Stock Awaits Next Move In A Base; Its Skin Drug Sales Grew 196%On May 6, Arcutis reported first-quarter results showed loss of 20 cents a share, which slightly beat estimates. Its sales ...
Stocks like Wipro, Axis Bank, LTIMindtree, Indian Hotels, Lupin, Tracxn Technologies, Capital Small Finance Bank, Veranda ...
8h
Investor's Business Daily on MSNLigand Pharmaceuticals Stock Earns 84 RS RatingLigand Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84.
Listen and subscribe to Stocks In Translation on Apple Podcasts, Spotify, or wherever you find your favorite podcast.Nvidia’s (NVDA) explosive growth is doing more than lifting portfolios - it’s ...
The new space is a free community service meant to help healthcare entrepreneurs connect with potential funders.
Clearside Biomedical will divert all employees to a consulting status and halt research-and-development, allowing the eye-care biotechnology firm to conserve cash during a search for a deal or other ...
This was the stock's second consecutive day of gains.
Regeneron Pharmaceuticals has recently launched a Phase 2 trial, testing the waters with a potential breakthrough in melanoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results